Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan
· Delayed Price · Currency is TWD 22.85
0.00 (0.00%)
Jun 30, 2025, 11:54 AM CST
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 676.02 million as of June 30, 2025. Its market cap has increased by 15.23% in one year.
Market Cap
676.02M
Enterprise Value
583.59M
Revenue
201.71M
Ranking
n/a
PE Ratio
674.67
Stock Price
22.85
Market Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 676.02M, a decrease of -65.17%. That is a compound annual growth rate of -19.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 676.02M | 6.39% |
| Dec 31, 2024 | 635.45M | -31.65% |
| Dec 29, 2023 | 929.63M | 3.17% |
| Dec 30, 2022 | 901.05M | -30.18% |
| Dec 30, 2021 | 1.29B | 56.23% |
| Dec 31, 2020 | 826.00M | -57.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 207.06B |
| PharmaEssentia | 177.30B |
| Bora Pharmaceuticals Co., LTD. | 84.51B |
| Lotus Pharmaceutical | 57.32B |
| Oneness Biotech | 32.52B |
| Polaris Group | 30.05B |
| Center Laboratories | 27.10B |
| Lumosa Therapeutics | 25.58B |